Esperie Burnet
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
French guidelines for severe asthma management
Journal: Revue des maladies respiratoires
Published: July 01, 2026
Outpatient Parenteral Antimicrobial Therapy in a Tertiary Hospital in France: A Description of Service Models and Costs.
Journal: Antibiotics (Basel, Switzerland)
Published: August 26, 2025
Identification of structural predictors of lung function improvement in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor using deep-learning.
Journal: Diagnostic and interventional imaging
Published: July 21, 2025
Bronchiectasis in France: data on disease characteristics in 630 patients from the European Bronchiectasis registry (EMBARC).
Journal: Respiratory medicine and research
Published: July 09, 2025
Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies.
Journal: The Lancet. Respiratory medicine
Published: March 27, 2025
Decreased insulin dose-adjusted hemoglobin A1c in adults with cystic fibrosis-related diabetes treated with elexacaftor-tezacaftor-ivacaftor.
Journal: Journal of clinical & translational endocrinology
Published: March 24, 2025
The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study.
Journal: The Lancet. Respiratory medicine
Published: April 11, 2024
Multisystemic Effects of Elexacaftor-Tezacaftor-Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease.
Journal: Annals of the American Thoracic Society
Published: April 05, 2024
CT imaging shows specific pancreatic abnormalities in persons with cystic fibrosis related diabetes.
CT imaging shows specific pancreatic abnormalities in persons with cystic fibrosis related diabetes.
Journal: Scientific reports
Published: February 10, 2023
The French compassionate programme of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease and no F508del CFTR variant.
Journal: The European respiratory journal
Published: December 20, 2022
CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France.
Journal: Cells
Published: April 01, 2022
The Changing Epidemiology of Cystic Fibrosis: The Implications for Adult Care.
Journal: Chest
Published: March 12, 2022
Last Updated: 09/26/2026